MODELING M-PROTEIN DYNAMICS IN SUBJECTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING VENETOCLAX: UTILITY OF EARLY M-PROTEIN MONITORING TO PREDICT PROGRESSION FREE SURVIVAL

被引：0
|
作者：
Liu, S. [1 ]
Salem, A. [1 ]
Ross, J. [1 ]
Bueno, O. [1 ]
Badawi, M. [1 ]
机构：
[1] AbbVie, Chicago, IL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-059
引用
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [41] A Personalized Mass Spectrometry-Based Assay to Monitor M-Protein in Patients with Multiple Myeloma (EasyM)
    Liyasova, Mariya
    McDonald, Zac
    Taylor, Paul
    Gorospe, Kathleen
    Xu, Xin
    Yao, Chenyu
    Liu, Qixin
    Yang, Liqiang
    Atenafu, Eshetu G.
    Piza, Giovanni
    Ma, Bin
    Reece, Donna
    Trudel, Suzanne
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (18) : 5028 - 5037
  • [42] Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM)
    Fan, Huishou
    Wang, Bing
    Shi, Lihui
    Pan, Ni
    Yan, Wenqiang
    Xu, Jingyu
    Gong, Lixin
    Li, Lingna
    Liu, Yuntong
    Du, Chenxing
    Cui, Jian
    Zhu, Guoqing
    Deng, Shuhui
    Sui, Weiwei
    Xu, Yan
    Yi, Shuhua
    Hao, Mu
    Zou, Dehui
    Chen, Xiequn
    Qiu, Lugui
    An, Gang
    [J]. CLINICAL CANCER RESEARCH, 2024, 30 (06) : 1131 - 1142
  • [43] M-PROTEIN KINETICS IN MULTIPLE-MYELOMA TREATED WITH MELPHALAN, IFOSFAMIDE, PREDNISOLONE, NITROSOUREA AND VINCRISTINE IN COMBINATION
    ISHII, H
    [J]. ACTA MEDICA OKAYAMA, 1988, 42 (05) : 279 - 286
  • [44] The utility of the follow-up with serum-free light chain after autologous stem cell transplantation in multiple myeloma patients with measurable M-protein
    Sohn, B. S.
    Kim, E. K.
    Yoon, D. H.
    Kang, M. J.
    Choi, D. R.
    Ahn, H. J.
    Cho, Y. J.
    Kim, K.
    Lee, D. H.
    Kim, S.
    Suh, C.
    Lee, J. S.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S426 - S427
  • [45] Elevated normal immunoglobulins and stable M-protein levels in multiple myeloma patients on erythropoietin treatment.
    Gadassi, Noa
    Sagiv, Sari Prutchi
    Oster, Howard S.
    Newmann, Drorit
    Mittelman, Moshe
    [J]. BLOOD, 2007, 110 (11) : 260B - 260B
  • [46] Update on the Outcome of M-Protein Screening Program of Multiple Myeloma in China: A 7-Year Cohort Study
    Wang, Wenjing
    Li, Jing
    Yang, Yang
    Chen, Feifei
    Xu, Tianhong
    Wang, Pu
    Wang, Yawen
    Maihemaiti, Aziguli
    Ren, Liang
    Liu, Peng
    [J]. BLOOD, 2022, 140 : 10097 - 10098
  • [47] Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels
    Heaney, Jennifer L. J.
    Richter, Alex
    Bowcock, Stella
    Pratt, Guy
    Child, J. Anthony
    Jackson, Graham
    Morgan, Gareth
    Turesson, Ingemar
    Drayson, Mark T.
    [J]. HAEMATOLOGICA, 2020, 105 (04)
  • [48] Update on the outcome of M-protein screening program of multiple myeloma in China: A 7-year cohort study
    Wang, Wenjing
    Li, Jing
    Yang, Yang
    Chen, Feifei
    Xu, Tianhong
    Wang, Pu
    Wang, Yawen
    Maihemaiti, Aziguli
    Ren, Liang
    Lan, Tianwei
    Li, Panpan
    Zhou, Chi
    Liu, Peng
    [J]. CANCER MEDICINE, 2024, 13 (01):
  • [49] A new free light chain immunoassay shows better agreement with the quantification of the serum protein electrophoresis M-protein compared to a nephelometric assay in patients with multiple myeloma
    Van Helden, J.
    Evliyaoglu, O.
    Dressen, D.
    Weiskirchen, R.
    [J]. CLINICA CHIMICA ACTA, 2019, 493 : S128 - S128
  • [50] Isatuximab-Specific Immunofixation Electrophoresis Assay to Remove Interference in Serum M-Protein Measurement in Patients with Multiple Myeloma
    Thoren, Katie
    Menad, Samia
    Nouadje, Georges
    Mace, Sandrine
    [J]. JOURNAL OF APPLIED LABORATORY MEDICINE, 2024,
12345